Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07413263
Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism
Official title: Impact of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
75
Start Date
2026-05-01
Completion Date
2028-12-30
Last Updated
2026-02-18
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
these drugs used in CML only